Showing results (1331-1340 of 1,540) with videos related to

Sort By:
Pageof 154
Mbio|February 25, 2025
<i>Campylobacter jejuni</i> resistance to human milk involves the acyl carrier protein AcpPBibi Zhou, Jolene M Garber, James Butcher, et al.
Cancer Chemotherapy and Pharmacology|June 24, 2016
TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancerD Ferraro, D Goldstein, R L O'Connell, et al.
The Journal of Clinical Investigation|July 13, 2011
Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesisHai Feng, Alfred S L Cheng, Daisy P Tsang, et al.
Frontiers in Systems Biology|August 14, 2025
Forecasting SARS-CoV-2 spike protein evolution from small data by deep learning and regressionSamuel King, Xinyi E Chen, Sarah W S Ng, et al.
Nature Communications|September 3, 2024
Efficient generation of human NOTCH ligand-expressing haemogenic endothelial cells as infrastructure for in vitro haematopoiesis and lymphopoiesisShicheng Sun, Ali Motazedian, Jacky Y Li, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 20, 2019
Associations of physical activity levels and screen time with oral glucose tolerance test profiles in Singaporean women of reproductive age actively trying to conceive: the S-PRESTO studyJ Y Bernard, S Ng, P Natarajan, et al.
The Journal of Urology|September 8, 2005
Multi-institutional validation study of neural networks to predict duration of stay after laparoscopic radical/simple or partial nephrectomySijo J Parekattil, Inderbir S Gill, Erik P Castle, et al.
International Journal of Antimicrobial Agents|June 21, 2016
Virological response to peramivir treatment in adults hospitalised for influenza-associated lower respiratory tract infectionsN Lee, P K S Chan, W W S Tam, et al.
Diabetes Care|January 30, 2007
Effects of treatment targets on subsequent cardiovascular events in Chinese patients with type 2 diabetesAlice P S Kong, Xilin Yang, Gary T C Ko, et al.
Investigational New Drugs|May 9, 2012
Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell linesBrigette B Y Ma, Vivian W Y Lui, Crystal S Cheung, et al.
Pageof 154